The import price of Azithromycin Dihydrate into the United States in January 2026 experienced a notable decrease, attributed to several factors such as post-holiday rebalancing, enhancements in freight logistics, and cautious purchasing by pharmaceutical formulators.
The market in the United States had undergone several months of significant fluctuations and subsequent re-stocking towards the end of 2025. However, a temporary alleviation in the price pressures of Azithromycin Dihydrate was observed as manufacturers modified their production levels, and distributors curtailed their short-term purchasing activities.
Analysts have indicated that this trend aligns with seasonal patterns for generic active pharmaceutical ingredients (APIs), where corrections typically occur in the first year following peak purchasing periods. Looking ahead, a modest rise in prices is anticipated as January 2026 commences, with formulators preparing to fulfill their standard purchasing volumes of Azithromycin Dihydrate.. Although current supplies are meeting demands, possible logistical issues in the trade environment may contribute to the eventual normalizing of prices in the US market of Azithromycin Dihydrate.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
